Manufacturers of drugs, devices, biological products and medical supplies would be required to annually report payments and other transfers of value to physicians and teaching hospitals under a final rule sent to the Office of Management and Budget for review.

OMB review is one of the final steps before publication of a rule. This final rule from the Centers for Medicare and Medicaid Services, mandated under the health reform law, also would require manufacturers and group purchasing organizations to annually report physician ownership stakes or investment interests.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access